Medidata and Tigermed Renew Strategic Partnership

Medidata, a Dassault Systèmes brand, has extended its 13-year relationship with Tigermed to further harness the Medidata Platform from early-phase trials to post-marketing surveillance, which will optimize study workflows, ensure regulatory compliance, and improve the speed of delivering new therapies to patients worldwide, including the emerging markets.

“Tigermed exemplifies the evolving role of CROs in driving efficiencies across the clinical trial process,” said Edwin Ng, senior vice president and general manager, APAC, Medidata. “Through this partnership, we’re able to jointly push the boundaries of trial management, improving the study experiences and ultimately delivering better outcomes for patients and sponsors around the world.”

Since adopting the Medidata Platform in 2011, Tigermed has successfully completed more than 300 clinical studies across diverse therapeutic areas, including oncology, vaccines, endocrine, and cardiovascular conditions. Built on a longstanding relationship, Tigermed will continue to leverage the Medidata Platform to seamlessly integrate with its workflow, automating data capture and streamlining operations traditionally reliant on labor-intensive contract research organization (CRO) services. This collaboration will improve trial efficiency, connecting patients, sites, and sponsors, shortening time to market for new products.

“Our partnership with Medidata has allowed our customers to make informed, data-driven decisions and achieve milestones faster,” stated Hao Wu, executive director and co-president, Tigermed. “We are delighted to extend this collaboration and look forward to leveraging more of Medidata’s technologies, including Medidata AI, as we shape the future of clinical trials worldwide.”

Medidata is powering smarter treatments and healthier people through digital solutions to support clinical trials. Celebrating 25 years of technological innovation across more than 35,000 trials and 10 million patients, Medidata offers expertise, analytics-powered insights, and reportedly the world’s largest patient-level historical clinical trial data set. More than 1 million registered users across approximately 2,300 customers use Medidata’s seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster. A Dassault Systèmes brand, Medidata is headquartered in New York City.

Dassault Systèmes is a catalyst for human progress. Since 1981, the company has pioneered virtual worlds to improve real life for consumers, patients and citizens. With Dassault Systèmes’ 3DEXPERIENCE platform, 350,000 customers of all sizes, in all industries, can collaborate, imagine and create sustainable innovations that drive meaningful impact.

Tigermed provides integrated research and development solutions for the biopharmaceutical and medical device industry. With a portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, the company collaborates with more than 3,200 customers and is committed to moving their development journey efficiently and cost-effectively. Tigermed currently represents a worldwide network of more than 180 locations with over 10,000 employees in Asia Pacific, Europe, North America, Latin America ,and Africa. Tigermed builds an integrated platform that enables the boundless possibilities for the healthcare industry, embracing challenges to fulfill our commitment to serving unmet patients’ needs.